Comparison of Anticoagulation with Left Atrial Appendage Closure after AF Ablation
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation (OPTION)
Sponsor: Boston Scientific Corporation
Enrolling: Male and Female Patients
IRB Number: AAAS7799
U.S. Govt. ID: NCT03795298
Contact: Cathy Moore: 212-342-3490 / cjm2285@cumc.columbia.edu
Additional Study Information: This study is a prospective, randomized, multi-center, global investigation to determine if left atrial appendage closure with the WATCHMAN FLX Device is a reasonable alternative to oral anticoagulation in patients after AF ablation.
This study is closed
Investigator
Amardeep Saluja, MD
Do You Qualify?
Do you have atrial fibrillation? Yes No
Do you have a mechanical heart valve implant? Yes No
Have you had an atrial septal repair or a left atrial appendage closure? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Cathy Moore
cjm2285@cumc.columbia.edu
212-342-3490
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE